Order Article Reprints

Wenger KJ, Richter C, Burger MC, Urban H, Kaulfuss S, Harter PN, Sreeramulu S, Schwalbe H, Steinbach JP, Hattingen E, et al. Non-Invasive Measurement of Drug and 2-HG Signals Using ¹⁹F and ¹H MR Spectroscopy in Brain Tumors Treated with the Mutant IDH1 Inhibitor BAY1436032. Cancers. 2020; 12(11):3175. https://doi.org/10.3390/cancers12113175

Wenger, Katharina J., Christian Richter, Michael C. Burger, Hans Urban, Stefan Kaulfuss, Patrick N. Harter, Sridhar Sreeramulu, Harald Schwalbe, Joachim P. Steinbach, Elke Hattingen, and et al. 2020. "Non-Invasive Measurement of Drug and 2-HG Signals Using ¹⁹F and ¹H MR Spectroscopy in Brain Tumors Treated with the Mutant IDH1 Inhibitor BAY1436032" Cancers 12, no. 11: 3175. https://doi.org/10.3390/cancers12113175

Wenger, K. J., Richter, C., Burger, M. C., Urban, H., Kaulfuss, S., Harter, P. N., Sreeramulu, S., Schwalbe, H., Steinbach, J. P., Hattingen, E., Bähr, O., & Pilatus, U. (2020). Non-Invasive Measurement of Drug and 2-HG Signals Using ¹⁹F and ¹H MR Spectroscopy in Brain Tumors Treated with the Mutant IDH1 Inhibitor BAY1436032. Cancers, 12(11), 3175. https://doi.org/10.3390/cancers12113175